Helius Average Receivables from 2010 to 2025
| HSDT Stock | USD 0.40 0.01 2.44% |
Average Receivables | First Reported 2010-12-31 | Previous Quarter 183.6 K | Current Value 163.2 K | Quarterly Volatility 11.1 K |
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 9.6 M, Other Operating Expenses of 16.1 M or Research Development of 6 M, as well as many indicators such as Price To Sales Ratio of 33.18, Dividend Yield of 0.0 or PTB Ratio of 18.01. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
Helius | Average Receivables |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.